All Participants | Male | Female | P1 | Kidney donor candidates | P2 | |
---|---|---|---|---|---|---|
n | 210 | 126 (60%) | 84 (40%) | 36 | ||
Age | 52.5 (16–85) | 57 (16–85) | 39.5 (16–83) | < 0.01 | 50 (20-76) | n.s. |
Height (cm) | 163 (144–184) | 167 (151–184) | 157 (144–168) | < 0.01 | 162 (144-184) | n.s. |
Weight (kg) | 59.8 (33.1–115.2) | 63.0 (34.5–103.0) | 52.3 (33.1–115.2) | < 0.01 | 53.8 (41.2-85.5) | < 0.05 |
BSA (m2) | 1.63 (1.20–2.20) | 1.72 (1.28–2.13) | 1.50 (1.20–2.20) | < 0.01 | 1.59 (1.28-2.00) | n.s. |
Diabetes, n (%) | 32 (15%) | 26 (21%) | 6 (7%) | < 0.01 | 5 (14%) | n.s. |
Alb (g/dL) | 3.7 (0.9–4.9) | 3.6 (1.2–4.9) | 3.8 (0.9–4.6) | n.s. | 3.9 (3.4-4.5) | < 0.01 |
Cr (mg/dL) | 1.13 (0.45–6.31) | 1.34 (0.63–6.31) | 0.80 (0.45–2.62) | < 0.01 | 0.86 (0.48-1.19) | < 0.01 |
Cys (mg/L) | 1.24 (0.52–5.67) | 1.45 (0.52–5.67) | 0.98 (0.53–2.37) | < 0.01 | 0.96 (0.58-1.64) | < 0.01 |
U-TP (g/day) | 0.5 (0–11.4) | 0.7 (0–11.4) | 0.3 (0–8.4) | < 0.05 | 0 (0-0.16) | < 0.01 |
U-Cr (mg/day) | 1025 (413–2012) | 1186 (568–2012) | 889 (413–1431) | < 0.05 | 936 (630-1783) | n.s. |